|
EXOC6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.120500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.788310E-02 |
| Normal-vs-Stage2 |
6.394000E-01 |
| Normal-vs-Stage3 |
1.028260E-04 |
| Normal-vs-Stage4 |
6.448200E-04 |
| Stage1-vs-Stage2 |
2.458200E-01 |
| Stage1-vs-Stage3 |
5.620000E-03 |
| Stage1-vs-Stage4 |
2.171800E-02 |
| Stage2-vs-Stage3 |
1.085710E-02 |
| Stage2-vs-Stage4 |
1.133950E-02 |
| Stage3-vs-Stage4 |
8.154000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.100100E-03 |
| Normal-vs-AfricanAmerican |
7.241500E-03 |
| Normal-vs-Asian |
5.404100E-02 |
| Caucasian-vs-AfricanAmerican |
4.954400E-01 |
| Caucasian-vs-Asian |
3.077000E-01 |
| AfricanAmerican-vs-Asian |
3.947600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.195500E-04 |
| Normal-vs-Female |
4.956300E-02 |
| Male-vs-Female |
1.377190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.262100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.828070E-02 |
| Normal-vs-Age(61-80Yrs) |
4.201600E-03 |
| Normal-vs-Age(81-100Yrs) |
3.599900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.625000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.998800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.620000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.713800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.195600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.783200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.179230E-01 |
| Normal-vs-Grade 2 |
5.884200E-02 |
| Normal-vs-Grade 3 |
3.206100E-04 |
| Normal-vs-Grade 4 |
3.00479999992831E-07 |
| Grade 1-vs-Grade 2 |
3.875800E-02 |
| Grade 1-vs-Grade 3 |
1.495780E-02 |
| Grade 1-vs-Grade 4 |
3.257200E-03 |
| Grade 2-vs-Grade 3 |
1.738500E-02 |
| Grade 2-vs-Grade 4 |
1.59024999999424E-05 |
| Grade 3-vs-Grade 4 |
4.724100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.514400E-01 |
| Normal-vs-ccB subtype |
3.69749999999947E-05 |
| ccA subtype-vs-ccB subtype |
1.94703999999435E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.053840E-02 |
| Normal-vs-N1 |
1.782060E-02 |
| N0-vs-N1 |
2.262800E-01 |
|
|
